Invention Grant
- Patent Title: Tri-salt form of metformin
-
Application No.: US14413996Application Date: 2013-07-10
-
Publication No.: US09382187B2Publication Date: 2016-07-05
- Inventor: Banavara L. Mylari , Frank C. Sciavolino
- Applicant: Thetis Pharmaceuticals LLC
- Applicant Address: US CT Southport
- Assignee: Thetis Pharmaceuticals LLC
- Current Assignee: Thetis Pharmaceuticals LLC
- Current Assignee Address: US CT Southport
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Agent Muriel Liberto, Esq.
- International Application: PCT/US2013/049984 WO 20130710
- International Announcement: WO2014/011814 WO 20140116
- Main IPC: A61K31/36
- IPC: A61K31/36 ; C07C57/03 ; A61K31/155 ; A61K45/06 ; C07C51/347 ; C07C229/24 ; A61K38/28 ; C07C279/26 ; C07C51/41

Abstract:
Provided herein are tri-salt compounds comprising a compound having two acidic functional groups and one basic functional groups (e.g., aspartate or glutamate), metformin, and polyunsaturated fatty acids, such as eicosapentaenoate or docosahexaenoate. The salts can be used in the treatment of diabetes, diabetes with concomitant dyslipidemia (e.g., high triglycerides) and diabetes exacerbated cardiovascular complications, such as cardiac arrhythmia, cardiac ischemia, myocardial infarction, cardiomyopathy, and stroke. The compounds of this invention are also useful in treating obesity.
Public/Granted literature
- US20150197475A1 Tri-Salt Form of Metformin Public/Granted day:2015-07-16
Information query